Abdel G. Babiker

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Pancreatic cancer, alcohol, diabetes mellitus and gall‐bladder disease

Jack Cuzick, Abdel G. Babiker · International Journal of Cancer · 1989 · 198 citations

Medicine, Oncology, Cancer Control +13

Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

François Raffi, Abdel G. Babiker, Laura Richert et al. · The Lancet · 2014 · 176 citations

Pharmacy, Infectious Diseases, Pharmacology +13

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Richard T. Davey, Eduardo Fernández‐Cruz, Norman Markowitz et al. · The Lancet Respiratory Medicine · 2019 · 134 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Thomas L Holland, Adit A. Ginde, Roger Paredes et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +4